Cardiology (all articles)
Consensus Document: Multimodality imaging in patients with heart failure and preserved ejection fraction.
10 Nov, 2021 | 07:09h | UTC
Review: Cardiogenic shock after acute myocardial infarction.
10 Nov, 2021 | 07:03h | UTCCardiogenic Shock After Acute Myocardial Infarction: A Review – JAMA (free for a limited period)
Systematic Review: Exercise‐based cardiac rehabilitation for coronary heart disease.
9 Nov, 2021 | 01:21h | UTCSummary: Exercise-based rehabilitation for coronary heart disease – Cochrane Library
Original Study: Exercise‐based cardiac rehabilitation for coronary heart disease – Cochrane Library
Lessons from a Superb Clinical Trial – commentary on a recent randomized trial testing left atrial appendage occlusion during cardiac surgery to prevent stroke.
9 Nov, 2021 | 01:08h | UTCLessons from a Superb Clinical Trial – by Dr. John Mandrola
Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
7 Nov, 2021 | 20:29h | UTCRelated:
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Among patients with atrial fibrillation, 4-year outcomes of PRAGUE-17 randomized trial showed that left atrial appendage closure was noninferior to non-warfarin oral anticoagulation for preventing net ischemic and bleeding events.
7 Nov, 2021 | 20:15h | UTCLeft Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17 – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term – TCTMD
Commentary on Twitter
📌 The PRAGUE-17 trial showed that left atrial appendage occlusion was noninferior to a #NOAC at preventing net ischemic & bleeding events. Check out ACC’s Visual Abstract from #TCT2021 to learn more here: https://t.co/NTVc4wpH6W pic.twitter.com/9EBWRvs72O
— American College of Cardiology (@ACCinTouch) November 6, 2021
RCT: In patients with advanced chronic kidney disease and poorly controlled hypertension, Chlortalidone had a significant impact in blood-pressure control (−11.0 mm Hg vs. −0.5 mm Hg in the placebo group).
7 Nov, 2021 | 20:20h | UTCChlorthalidone for Hypertension in Advanced Chronic Kidney Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Cheap Diuretic, Chlorthalidone, Drops BP in Advanced Kidney Disease – Medscape (free registration required)
Commentary on Twitter
In this placebo-controlled trial involving patients with advanced chronic kidney disease and poorly controlled hypertension, chlorthalidone therapy improved blood-pressure control at 12 weeks as compared with placebo. #KidneyWk https://t.co/iNZc2mYy2c pic.twitter.com/7svX4RVtPI
— NEJM (@NEJM) November 5, 2021
New study challenges the idea that a coronary artery calcium score of 0 is enough for ruling out coronary stenosis in symptomatic patients, especially in young adults.
7 Nov, 2021 | 20:09h | UTCAssociation of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients – JAMA Cardiology (link to abstract – $ for full-text)
Commentary: Zero CAC Questionable for Ruling Out Obstructive CAD in Young Adults – TCTMD
Commentary from the author on Twitter (thread – click for more)
There has been a lot of discussion about our recent paper in JAMA Cardiology. In my opinion, much of the discussion is caused by a troublesome extrapolation of the results to the value of CAC in risk assessment in primary prevention. I will go through our findings in these tweets https://t.co/O0Rl12XYmV
— Martin Bødtker Mortensen (@MaBMortensen) November 1, 2021
M-A: Renal denervation for hypertension is associated with a modest reduction in ambulatory blood pressure control (3.61 mm Hg reduction in ambulatory systolic BP and 1.85 mm Hg reduction in ambulatory diastolic BP).
5 Nov, 2021 | 09:46h | UTCCommentaries:
Meta-Analysis of Renal Denervation for Hypertension – American College of Cardiology
Is Renal Denervation a Useful Strategy in BP Management? – American College of Cardiology
Related:
RCT: In patients with three-vessel coronary artery disease, an FFR–guided PCI strategy was NOT noninferior to coronary bypass surgery – The 1-year incidence of the composite primary end point (death, myocardial infarction, or stroke) was 7.3% in the FFR-guided PCI group and 5.2% in the CABG group.
5 Nov, 2021 | 09:49h | UTCCommentaries:
FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD – TCTMD
FAME 3: FFR-Guided PCI vs. CABG in Patients With Three-Vessel CAD – American College of Cardiology
Commentary on Twitter
In this trial, patients with three-vessel coronary artery disease, PCI guided by assessment of fractional flow reserve was not noninferior to CABG with respect to the composite end point of death, myocardial infarction, stroke, or repeat revascularization. https://t.co/uYZGZWub0T pic.twitter.com/zsghs2SlsA
— NEJM (@NEJM) November 4, 2021
Spontaneous coronary artery dissection: Principles of management.
4 Nov, 2021 | 09:52h | UTCRelated:
Spontaneous Coronary Artery Dissection: Clinical Considerations in Diagnosis and Treatment
Review: Spontaneous Coronary Artery Dissections and Associated Predisposing Factors
Study: Natural History of Spontaneous Coronary Artery Dissection
Spontaneous Coronary Artery Dissection: An Often Unrecognized Cause of Acute Coronary Syndrome
ESC position paper on spontaneous coronary artery dissection
Guideline: Spontaneous Coronary Artery Dissection
Study: Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence
Short Review: Cardiac injury in Covid-19.
3 Nov, 2021 | 10:04h | UTCCardiac injury in COVID-19 – Intensive Care Medicine
Commentary on Twitter
Myocardial injury in #COVID19, many potential mechanisms:
🫀myocardial DO2/VO2 imbalance
🫀ARDS & MV
🫀cytokine storm
🫀direct viral lesion.
Variable clinical presentations, with high complications rates, mortality & risk of long-term cardiac impairment.https://t.co/wxPDDrtEoY pic.twitter.com/vOx1B4cwY2— Intensive Care Medicine (@yourICM) November 2, 2021
AHA Scientific Statement: 2021 Dietary Guidance to Improve Cardiovascular Health.
3 Nov, 2021 | 10:00h | UTCNews release: New look at nutrition research identifies 10 features of a heart-healthy eating pattern – American Heart Association
Top Things to Know: 2021 Dietary Guidance to Improve Cardiovascular Health – American Heart Association
Commentaries:
‘Balance’ is the key word in new dietary guidance for heart health – American Heart Association
Commentary on Twitter
CHOOSE MINIMALLY PROCESSED FOODS INSTEAD OF ULTRA-PROCESSED FOODS is one of the 10 evidence-based dietary pattern recommendations in the new excellent 2021 American Heart Association Scientific Statement on Dietary Guidance to Improve Cardiovascular Healthhttps://t.co/YgtDKz05EP
— Carlos A. Monteiro (@CMonteiro_USP) November 2, 2021
A comprehensive review of vascular complications in COVID-19.
2 Nov, 2021 | 03:01h | UTC
Cohort Study: Among patients with ST-segment elevation myocardial infarction, a concomitant Covid-19 diagnosis is associated with increased in-hospital mortality.
31 Oct, 2021 | 20:10h | UTCEditorial: Myocardial Infarction During the COVID-19 Pandemic – JAMA
Commentary: STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet – TCTMD
Commentary from the author on Twitter (thread – click for more)
1/8 It was not unexpected that pts w/ #STEMI would fare worse w/ than w/o #COVID19 https://t.co/B7oWnJunEa
— herbaronowMD (@herbaronowMD) October 29, 2021
RCT: Targeting higher intraoperative blood pressures does not reduce adverse cardiovascular events following noncardiac surgery.
31 Oct, 2021 | 20:00h | UTC
Cardiovascular clinical examination: the need for an evidence-based approach.
31 Oct, 2021 | 19:57h | UTC
Commentary on Twitter
Which role for cardiac clinical examination today?
According to new cardiopulse, cardiac physical diagnosis shold be regarded as a science that can be learnt, rather than an art that can only be aspired to.https://t.co/oG1NJusXrS#cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/B9iUSv0gnj— EHJ Editor-in-Chief (@ehj_ed) October 30, 2021
Study suggests smoking cessation, but not reduction, is associated with reduced risk of cardiovascular disease.
31 Oct, 2021 | 19:59h | UTCSmoking cessation, but not reduction, reduces cardiovascular disease incidence – European Heart Journal (link to abstract – $ for full-text)
Commentary on Twitter
May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.https://t.co/lVgXMwavNs#smoke, #cigarettes, #MI, #cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/FrqB5V2tx3
— EHJ Editor-in-Chief (@ehj_ed) October 31, 2021
2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain.
29 Oct, 2021 | 09:57h | UTCExecutive Summary: 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain – Journal of the American College of Cardiology
News Release: First-Ever Guideline Focused Solely on Chest Pain Evaluation, Diagnosis Released
Guideline Hub: Guideline for the Evaluation and Diagnosis of Chest Pain
Key Points: 2021 AHA/ACC Chest Pain Guideline – American College of Cardiology
Commentary: New Chest Pain Guidelines Out at Last: Most Tests Have a Role – TCTMD
Commentary on Twitter (thread – click for more)
The Chest Pain Guidelines are now released!https://t.co/xQxCWzReEN
Top 10: CHEST PAINS
Thanks to the entire writing group and my co-cahirs: Deb Murkerjee & Phil Levy
💥First Chest Pain Guidelines @AHAScience @ACCinTouch pic.twitter.com/s17piamrKR— Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 (@DrMarthaGulati) October 28, 2021
Systematic Review: Not enough evidence to inform the decision to either interrupt or continue anticoagulation before catheter ablation in patients with arrhythmia.
29 Oct, 2021 | 09:50h | UTC
Systematic Review: GLP-1 receptor agonists and SGLT-2 inhibitors are likely to reduce the risk of death from cardiovascular disease and death from any cause in people with both diabetes and established cardiovascular disease.
29 Oct, 2021 | 09:52h | UTC
Commentary on Twitter
The effects of DPP‐4 inhibitors, GLP‐1 receptor agonists and SGLT‐2 inhibitors for people with #CardiovascularDisease https://t.co/0FwffSCqbC New @CochraneHeart network meta-analysis looks at evidence from 31 studies. #CardiovascularResearch
— The Cochrane Library (@CochraneLibrary) October 27, 2021
Brain injury after cardiac arrest: pathophysiology, treatment, and prognosis.
29 Oct, 2021 | 09:49h | UTC
Commentary on Twitter
Post-cardiac arrest brain injury, narrative review:
🧠pathophysiology: primary (ischemic) & secondary (reperfusion)
🧠treatment options
🧠outcomes
🧠neuroprognostication
🧠@ERC_resus @ESICM 2021 algorithm for prognostication
Open #FOAMcc #FOAMres @yourICM https://t.co/b8GRhE3MuF pic.twitter.com/q10DJVRJOp— Intensive Care Medicine (@yourICM) October 27, 2021
Stimulant prescription linked to increased short-term risks of cardiovascular events in older adults.
29 Oct, 2021 | 09:47h | UTCAssessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults – JAMA Network Open
Commentaries:
Stimulants Linked to Early Risk of CV Events in Elderly – TCTMD
Stimulants May Pose Short-Term Cardiovascular Risks in Older Adults – Psychiatric News Alert
ESC Consensus Document | Frailty in cardiology: definition, assessment and clinical implications for general cardiology.
28 Oct, 2021 | 09:59h | UTC
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
26 Oct, 2021 | 01:26h | UTCEditorial: QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
Commentary: Anticancer Drug-Induced Life-Threatening Ventricular Arrhythmias – American College of Cardiology
Commentary on Twitter
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization @WHO pharmacovigilance study https://t.co/ONAIFmOjZV #EHJ #ESCYoung #ventriculararrhythmias #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/t0fjoVy7fw
— European Society of Cardiology Journals (@ESC_Journals) August 23, 2021


